NeuroBo Pharmaceuticals, Inc. (GEMP) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	17.3	12.2	8.8	0.0	0.0	0.9	0.0
Gross profit	0.0	-17.3	-12.2	-8.8	0.0	0.0	-0.9	0.0
Selling, general and administrative [+]	8.8	7.8	2.7	1.6	10.4	6.0	3.2	0.2
General and administrative	8.8	7.8	2.7	1.6	10.4	6.0	3.2	0.2
Research and development	6.5	4.5	5.3	5.1	22.7	8.7	4.0	0.1
EBITDA [+]	-15.3	-29.7	-20.2
EBITDA growth	-48.6%	47.2%	30.2%	-53.2%	125.4%	82.0%	2936.1%
Depreciation and amortization	0.0	0.0	0.0
EBIT [+]	-15.3	-29.7	-20.2	-15.5	-33.1	-14.7	-8.1	-0.3
EBIT growth	-48.5%	47.3%	30.3%	-53.2%	125.4%	82.0%	2936.1%
Interest expense, net [+]	0.0	0.0	0.0	0.0	0.3	-0.1	0.8	0.1
Interest expense			0.0	0.0	0.3		0.8	0.1
Interest income	0.0	0.0				0.1
Other income (expense), net [+]		0.0	-1.1	0.0	0.0	0.0	-0.2	0.0
Gain (loss) on debt retirement			-1.1				-0.2
Other		0.0		0.0	0.0	0.0	0.0	0.0
Pre-tax income	-15.3	-29.7	-21.3	-15.5	-33.4	-14.6	-9.0	-0.3
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-15.3	-29.7	-21.3	-15.5	-33.4	-15.0	-13.0	-0.3

Basic EPS [+]	($0.66)	($1.83)	($4.08)	($3.65)	($3.23)	($2.57)	($4.54)	($0.21)
Growth	-63.9%	-55.1%	11.7%	13.1%	25.4%	-43.3%	2057.5%
Diluted EPS [+]	($0.66)	($1.83)	($4.08)	($3.65)	($3.23)	($2.57)	($4.54)	($0.21)
Growth	-63.9%	-55.1%	11.7%	13.1%	25.4%	-43.3%	2057.5%

Shares outstanding (basic) [+]	23.1	16.2	5.2	4.3	10.3	5.8	2.9	1.5
Growth	42.7%	210.4%	22.9%	-58.9%	78.1%	102.1%	88.9%
Shares outstanding (diluted) [+]	23.1	16.2	5.2	4.3	10.3	5.8	2.9	1.5
Growth	42.7%	210.4%	22.9%	-58.9%	78.1%	102.1%	88.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.